TrialThe Lancet. Respiratory medicine2021

Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.

Barry Dixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.